Coherus BioSciences, Inc. Forecast, price target & analysts
Coherus BioSciences, Inc. Target price 2025 - Analyst rating & recommendation
Coherus BioSciences, Inc. Classifications & Recommendation:
Coherus BioSciences, Inc. Price Target
| Target Price | $4.68 |
| Price | $1.03 |
| Potential |
354.69%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Coherus BioSciences, Inc. 2026 .
The average Coherus BioSciences, Inc. target price is $4.68.
This is
354.69%
register free of charge
$7.00
579.61%
register free of charge
$1.05
1.94%
register free of charge
|
|
| A rating was issued by 6 analysts: 4 Analysts recommend Coherus BioSciences, Inc. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Coherus BioSciences, Inc. stock has an average upside potential 2026 of
354.69%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 266.96 | 99.27 |
| 3.78% | 62.82% | |
| EBITDA Margin | -37.32% | -116.20% |
| 49.32% | 211.39% | |
| Net Margin | 10.83% | 6.54% |
| 109.52% | 39.59% |
6 Analysts have issued a sales forecast Coherus BioSciences, Inc. 2025 . The average Coherus BioSciences, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Coherus BioSciences, Inc. EBITDA forecast 2025. The average Coherus BioSciences, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Coherus BioSciences, Inc. Analysts have issued a net profit forecast 2025. The average Coherus BioSciences, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.25 | 0.06 |
| 109.88% | 76.00% | |
| P/E | 18.35 | |
| EV/Sales | 2.94 |
5 Analysts have issued a Coherus BioSciences, Inc. forecast for earnings per share. The average Coherus BioSciences, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Coherus BioSciences, Inc....
Current Coherus BioSciences, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Locked
➜
Locked
|
Locked | Apr 24 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 11 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 23 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 22 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Dec 05 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 04 2024 |
| Baird |
Locked
➜
Locked
|
Locked | Nov 08 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
UBS:
Locked
➜
Locked
|
Apr 24 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 11 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 23 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 22 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Dec 05 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 04 2024 |
|
Locked
Baird:
Locked
➜
Locked
|
Nov 08 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
